M&A Deal Summary |
|
|---|---|
| Date | 2016-06-28 |
| Target | Norgine - Middle East & North Africa Operations & Product Right |
| Sector | Life Science |
| Buyer(s) | Acino |
| Sellers(s) | Norgine |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 7 |
| Sector (Life Science) | 2 of 4 |
| Type (Divestiture) | 1 of 5 |
| Country (Netherlands) | 1 of 1 |
| Year (2016) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-10-07 |
Pharma Start
Kyiv, Ukraine Pharma Start covers the entire value chain from development, manufacturing and registration to distribution, marketing and sales. Pharma Start, the 9th largest local pharmaceutical company in Ukraine. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-30 |
Acino Holding AG - Transdermal Drug Delivery Systems Business
Aesch, Czech Republic Acino Holding AG - Transdermal Drug Delivery Systems Business includes Acino’s transdermal manufacturing operations in Miesbach, Germany, distribution, and R&D capabilities. |
Sell | - |
Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (Netherlands) | 1 of 1 |
| Year (2016) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-01 |
Endocuff
Leeds, United Kingdom ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-05-11 |
Merus Labs International
Toronto, Ontario, Canada Merus Labs International, Inc. is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform across Europe, Canada and select other markets to deliver value. |
Buy | $342M |
